Pfizer Inc. (FRA:PFE)
20.50
-0.27 (-1.28%)
May 13, 2025, 7:36 PM CET
Pfizer Revenue
Pfizer had revenue of $13.72B USD in the quarter ending March 30, 2025, a decrease of -7.82%. This brings the company's revenue in the last twelve months to $62.46B, up 11.65% year-over-year. In the year 2024, Pfizer had annual revenue of $63.63B with 6.84% growth.
Revenue (ttm)
$62.46B
Revenue Growth
+11.65%
P/S Ratio
2.05
Revenue / Employee
$771.16K
Employees
81,000
Market Cap
118.06B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 63.63B | 4.07B | 6.84% |
Dec 31, 2023 | 59.55B | -41.62B | -41.14% |
Dec 31, 2022 | 101.18B | 19.89B | 24.46% |
Dec 31, 2021 | 81.29B | 39.64B | 95.16% |
Dec 31, 2020 | 41.65B | 746.00M | 1.82% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Siemens Healthineers AG | 23.14B |
Merck KGaA | 21.16B |
Fresenius SE & Co. KGaA | 22.13B |
Bayer Aktiengesellschaft | 46.61B |
Fresenius Medical Care AG | 19.49B |
Sartorius Aktiengesellschaft | 3.44B |
Carl Zeiss Meditec AG | 2.08B |
Fielmann Group AG | 2.33B |
Pfizer News
- 6 hours ago - Pfizer, Eli Lilly, and Other Pharma Stocks Fall. Questions Remain About Trump's Executive Order. - Barrons
- 8 hours ago - Pfizergate and von der Leyen’s political long Covid - EURACTIV.com
- 8 hours ago - Jim Cramer Is 'OK' With Harrow, Recommends Buying This Energy Stock - Benzinga
- 9 hours ago - NVO, PFE and LLY Forecast – Pharma Stocks React to Drug Order Trump Signs - FX Empire
- 22 hours ago - Lightning Round: Devon Energy has been a nightmare, says Jim Cramer - CNBC
- 23 hours ago - 50 Fortune World's Most Admired Companies (FWMAC): 24 "Safer", 1 Ideal Buy - Seeking Alpha
- 1 day ago - Trump wants to slash U.S. drug prices with 'most favored nation' policy – here's what to know - CNBC
- 1 day ago - Drugmakers are spared worst-case drug pricing scenario for now - WSJ